We appreciate your patience as we fix inconsistencies in the study tracker and research databases.

  • Health Category:
  • Health Sub-Category:
  • Study Type:

  • Publish Date:

    -

Ossification of the posterior longitudinal ligament and fluorosis

There is only one report of ossification of the posterior longitudinal ligament (OPLL) in patients suffering from fluorosis. Deshpande, Dinakarand Reddy (1976) mention an association with fluorosis in 14 of 26 cases. OPLL is not mentioned in two reviews of fluorosis (Jolly 1981; Reddy and Reddy 1987). Patients. In our neurological service, we saw 15 cases of OPLL in one year, allpresenting with spinal compression. They accounted for about 1 .5% of all spinal cases. Ten of them had associated

Thoracic myelopathy from coincident fluorosis and epidural lipomatosis

Skeletal fluorosis is rare in North America. It can present with back pain and extremity weakness. Immobilization of the spine and the extremity joints can occur. It is usually caused by abnormally increased oral fluoride intake over many years. Epidural lipomatosis is usually caused by idiopathic obesity or corticosteroid use. It has been linked to highly active antiretroviral therapy (HAART) for human immunodeficiency virus (HIV). Fluorosis and epidural lipomatosis are each rare causes of comp

Prevalence and aetiology of juvenile skeletal fluorosis in the south-west of the Hai district, Tanzania–a community-based prevalence and case-control study

Fifty-six cases (34 males, 60.7%) of severe, deforming JSF were identified from the 1263 [691 females (54.7%) 88.0% of the entire village population] that were available for musculoskeletal examination. This represented a prevalence of 4.4% (95% CI, 3.3–5.6). Twenty-four cases of JSF (contained within 10 families) had at least one sibling who was also affected. The prevalence in males was 6.2% (95% CI, 4.2–8.2) and in females 3.1% (95% CI, 1.8–4.4). The age of the cases of JSF identified r

Renal failure and fluorosis

It is generally agreed that water fluoridation is safe for persons with normal kidneys. Systemic fluorosis in patients with diminished renal function, however, seems a reasonable possibility. In such patients, fluoride may be retained with resulting higher tissue fluoride levels than in persons with normal renal function.